(Q34535719)

2 August 2017

1 reference

title

Analysis of telomerase as a diagnostic biomarker of cervical dysplasia and carcinoma (English)

1 reference

2 August 2017

0 references

1 reference

Elke A Jarboe

1 reference

2 August 2017

Kai-Li Liaw

1 reference

2 August 2017

L Chesney Thompson

1 reference

2 August 2017

David E Heinz

1 reference

2 August 2017

Paige L Baker

1 reference

2 August 2017

Jamie A McGregor

1 reference

2 August 2017

Terry Dunn

1 reference

2 August 2017

Jan E Woods

1 reference

2 August 2017

Kenneth R Shroyer

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

664-673

1 reference

Effect of acetic acid on telomerase activity in cervical intraepithelial neoplasia

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Cytopathology of false negatives preceding cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

The RNA component of human telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Localization of telomerase hTERT protein and hTR in benign mucosa, dysplasia, and squamous cell carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Telomerase activity in human gynaecological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Screening for cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Effect of acetic acid on telomerase activity in premalignant and malignant cervical lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Telomerase Activation in Cervical Neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Telomerase activation by the E6 gene product of human papillomavirus type 16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Telomerase activity and human papillomavirus in malignant, premalignant and benign cervical lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Telomerase Catalytic Subunit Homologs from Fission Yeast and Human

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasia lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Association between human papillomavirus type and clonal status of cervical squamous intraepithelial lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Negative cytology preceding cervical cancer: causes and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

21 January 2018

Telomerase and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Evaluation of the 10% rescreen of negative gynecologic smears as a quality assurance measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

False negative rate in cervical cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

The molecular biology of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Limitations on the quantitative determination of telomerase activity by the electrophoretic and ELISA based TRAP assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Telomerase Activation inin Vitroandin VivoCervical Carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Papillomaviruses in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

Results of prior cytologic screening in patients with a diagnosis of Stage I carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

7 January 2021

Advanced squamous cell carcinoma of the cervix with recent normal Papanicolaou tests

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

7 January 2021

Clonal analysis of high-grade squamous intra-epithelial lesions of the uterine cervix

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

7 January 2021

Telomerase activity and human papillomavirus (HPV) infection in human uterine cervical cancers and cervical smears

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

7 January 2021

Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

7 January 2021

Molecular biology of cervical cancer and its precursors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

7 January 2021

Telomerase-A molecular marker for cervical cancer screening

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

7 January 2021

Relationship between telomerase activation and HPV 16/18 oncogene expression in squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

7 January 2021

Telomerase Expression in Normal Endometrium, Endometrial Hyperplasia, and Endometrial Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

7 January 2021

Telomerase expression in normal epithelium, reactive atypia, squamous dysplasia, and squamous cell carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

7 January 2021

Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

7 January 2021

Telomerase in relation to clinicopathologic prognostic factors and survival in cervical cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

7 January 2021

Telomerase activity in the female reproductive tract and neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

7 January 2021

Clinical significance of telomerase activation and telomeric restriction fragment (TRF) in cervical cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

7 January 2021

Papillomavirus infections--a major cause of human cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205073

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1205073

1 reference

Dimensions Publication ID

2 August 2017

1023613850

0 references

1 reference